title: Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.
authors.forename: Thomas
authors.initials: T
authors.lastname: Wendland
authors.forename: Barbara
authors.initials: B
authors.lastname: Daubner
authors.forename: Werner J
authors.initials: WJ
authors.lastname: Pichler
mesh_terms: D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002511:Cephalosporins / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D006801:Humans; D012293:Rifampin / Q000009:adverse effects; D013577:Syndrome; D014640:Vancomycin / Q000009:adverse effects
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; C443755:ceftobiprole; D014640:Vancomycin; D012293:Rifampin